Information for "ML20227A174"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | ML20227A174 |
| Redirects to | PMNS20201009, U.S. Food and Drug Administration (Fda) and U.S. Nuclear Regulatory Commission (NRC) Workshopenhancing Development of Emerging Technologies: Radiopharmaceuticals and Radiological Devices (info) |
| Default sort key | ML20227A174 |
| Page length (in bytes) | 214 |
| Page ID | 968269 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | StriderTol (talk | contribs) |
| Date of page creation | 09:45, 24 August 2020 |
| Latest editor | StriderTol (talk | contribs) |
| Date of latest edit | 09:45, 24 August 2020 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |